aspirin and arachidonyl-2-chloroethylamide

aspirin has been researched along with arachidonyl-2-chloroethylamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fereniec-Gołtbiewska, L; Rutkowska, M1
Fereniec-Gołebiewska, L; Rutkowska, M1

Other Studies

2 other study(ies) available for aspirin and arachidonyl-2-chloroethylamide

ArticleYear
ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration.
    Die Pharmazie, 2006, Volume: 61, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Aspirin; Dose-Response Relationship, Drug; Gastric Mucosa; Ranitidine; Rats; Receptor, Cannabinoid, CB1; Stomach Ulcer

2006
Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration.
    Die Pharmazie, 2009, Volume: 64, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Arginine; Aspirin; Enzyme Inhibitors; Female; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Stomach Ulcer

2009